Alexandra Balcom

Chief Financial Officer

Alexandra Balcom (Chief Financial Officer) filed 12 Form 4 reports in the trailing twelve months (0 purchases, 12 sales), most often in Nuvalent Inc (NUVL). The largest single filing was $3.5M of NUVL (39,800 sh across 6 lots, as filed), executed Oct 13 2025.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 12 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$18.0M

shares × price, as filed

Last traded

Jul 1

Filed Jul 6

Median ADV $288.8M across their filed names

Open performance→

Volume by month

Buys $0 Sells $24.2M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 12 filings

Sector per market data · by filing · past 12 months

Most traded names

NUVL

Nuvalent Inc NUVL · 0 buys · 18 sells 18 filings

Recent filings

NUVLSALE Nuvalent Inc View filing → $144K
1,683 sh × $85.57
Exec Oct 15 2025
Filed Oct 17 2025 · 5:30 PM ET NUVLSALE Nuvalent Inc View filing → $3.5M
39,800 sh across 6 lots
Exec Oct 13 2025
Filed Oct 15 2025 · 5:30 PM ET NUVLSALE Nuvalent Inc View filing → $1.6M
19,030 sh × $85.43
Exec Oct 1 2025
Filed Oct 3 2025 · 5:30 PM ET NUVLSALE Nuvalent Inc View filing → $2.3M
27,588 sh across 2 lots
Exec Sep 29 2025
Filed Oct 1 2025 · 5:30 PM ET NUVLSALE Nuvalent Inc View filing → $1.6M
19,072 sh across 3 lots
Exec Jul 15 2025
Filed Jul 17 2025 · 5:30 PM ET NUVLSALE Nuvalent Inc View filing → $1.6M
20,000 sh × $80.02
Exec Jun 27 2025
Filed Jul 1 2025 · 5:30 PM ET NUVLSALE Nuvalent Inc View filing → $175K
2,173 sh × $80.54
Exec Jan 6 2025
Filed Jan 8 2025 · 5:30 PM ET NUVLSALE Nuvalent Inc View filing → $958K
10,000 sh across 2 lots
Exec Nov 29 2024
Filed Dec 3 2024 · 5:30 PM ET More filings →